Ovid Therapeutics Inc. Underwriting Agreements

6 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement related to the Common Offering, dated February 20, 2019, among Ovid Therapeutics Inc. and Cowen and Company, LLC and William Blair & Company, L.L.C
Underwriting Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2019
Underwriting Agreement related to the Offering, dated August 25, 2020, among Ovid Therapeutics Inc. and Cowen and Company, LLC and William Blair & Company, L.L.C
Underwriting Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2020
Underwriting Agreement related to the Preferred Offering, dated October 4, 2019, among Ovid Therapeutics Inc. and Cowen and Company, LLC and William Blair & Company, L.L.C
Underwriting Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2019
Underwriting Agreement related to the Common Offering, dated October 4, 2019, among Ovid Therapeutics Inc. and Cowen and Company, LLC and William Blair & Company, L.L.C
Underwriting Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2019
Underwriting Agreement related to the Preferred Offering, dated February 20, 2019, among Ovid Therapeutics Inc. and Cowen and Company, LLC and William Blair & Company, L.L.C
Underwriting Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2019
Ovid Therapeutics Inc. [] Shares Common Stock ($0.001 par value) Underwriting Agreement
Underwriting Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2017